Generic Drug Approvals In US Off To Slow Start In FY 2020

group of businessman in black suit and holding red arrow down graph
The FDA says its generics program is healthy despite several months of below average ANDA full approval totals. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics